Macaulay Capital Plc

Report Publication Announcement • Dec 17, 2025

National Storage Mechanism | Additional information

RNS Number : 8223L

Macaulay Capital PLC

17 December 2025

17 December 2025  

Macaulay Capital PLC

("Macaulay Capital" or the "Company")

Amendment to the terms of warrants

Macaulay Capital PLC (AQSE:MCAP), which was formed to originate and manage corporate transactions, raise funds from third parties, invest its own funds alongside those of external investors and to manage its investment portfolio with the aim of maximising its value, announces an amendment to the terms of warrants.

Harry and Tom Horner (the adult sons of David Horner) each hold 450,000 unconditional founder warrants, which must be exercised by 31 December 2025, at a price of £0.25 per share ("Unconditional Founder Warrants").  They and Company have agreed to extend the date by which these warrants must be exercised, to 31 March 2026 ("Amendment to the Warrant Terms").

As David Horner is a director of the Company and Harry and Tom Horner are both substantial shareholders, the Amendment to the Warrant Terms is deemed to be a related party transaction under the AQSE Rules.  The Company's other directors, Lindsay Mair and Richard Bucknell, having exercised reasonable care, skill and diligence, believe that the Amendment to the Warrant Terms is fair and reasonable as far as the shareholders of the Company are concerned.

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

ENDS 

Enquiries:

Macaulay Capital PLC
Clive Milner	+44 (0)20 3946 5980
Cairn Financial Advisers LLP (AQSE Corporate Adviser)
Louise O'Driscoll	+44 (0)20 7213 0880
Oberon Capital (Broker)
Chris Crawford	+44 (0)20 3179 5304

For more information please visit: www.macaulaycapital.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXQQLFFELLXFBL